Showing results (1-10 of 160) with videos related to
Sort By:
Pageof 16
Current Opinion in Investigational Drugs (London, England : 2000)|July 2, 2002
Ravuconazole Eisai/Bristol-Myers SquibbSevtap Arikan, John H RexExpert Opinion on Emerging Drugs|July 2, 2005
New agents for the treatment of systemic fungal infections--current statusSevtap Arikan, John H RexAntimicrobial Agents and Chemotherapy|August 17, 2002
Comparative evaluation of disk diffusion with microdilution assay in susceptibility testing of caspofungin against Aspergillus and Fusarium isolatesSevtap Arikan, Victor Paetznick, John H RexAntimicrobial Agents and Chemotherapy|December 26, 2001
In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium sppSevtap Arikan, Mario Lozano-Chiu, Victor Paetznick, et al.Cellular & Molecular Biology Letters|October 16, 2002
Lipid-based antifungal agents: a concise overviewSevtap ArikanMedical Mycology|September 22, 2007
Current status of antifungal susceptibility testing methodsSevtap ArikanJournal of Clinical Microbiology|March 30, 2002
In vitro activity of nystatin compared with those of liposomal nystatin, amphotericin B, and fluconazole against clinical Candida isolatesSevtap Arikan, Luis Ostrosky-Zeichner, Mario Lozano-Chiu, et al.Annals of the New York Academy of Sciences|December 13, 2012
Azole resistance in Aspergillus: global status in Europe and AsiaSevtap Arikan-AkdagliJournal of Basic Microbiology|September 2, 2008
Investigation of extracellular elastase, acid proteinase and phospholipase activities as putative virulence factors in clinical isolates of Aspergillus speciesSehnaz Alp, Sevtap ArikanDiagnostic Microbiology and Infectious Disease|June 29, 2002
Comparison of NCCLS microdilution method and Etest in antifungal susceptibility testing of clinical Trichosporon asahii isolatesSevtap Arikan, Gülşen HasçelikPageof 16